Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of a peer-reviewed, retrospective outcomes study demonstrating ...
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD) today announced the results of a third-party, clinical study presented as a clinical abstract poster at the American Thoracic ...
Electromed specializes in HFCWO therapy with its SmartVest System, targeting respiratory diseases and leveraging a direct sales force for market penetration. The HFCWO market is consolidated, with ...
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE MKT:ELMD) today announced that a new study published in Respiratory Therapy: The Journal of Pulmonary Technique shows that consistent use of ...
September 15, 2009 (Vienna, Austria) — A pneumatic vest that provides high-frequency chest-wall oscillation (HFCWO) is a promising therapy for chronic mucus hypersecretion in patients with moderate to ...
International Biophysics Corporation, a global medical device manufacturer, announced two new patents have been issued from the United States Patent and Trademark Office (USPTO) for the company's ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of a peer-reviewed, retrospective outcomes study demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback